Results 231 to 240 of about 109,974 (359)
Association of antihypertensive agents with the risk of in-hospital death in patients with Covid-19
Chouchana L +9 more
europepmc +1 more source
Does comorbidity explain trends in prescribing of newer antihypertensive agents? [PDF]
Jacoba P. Greving +6 more
openalex +1 more source
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley +1 more source
Hemodynamic and myocardial anti-stunning effects of a new antihypertensive agent. S-2150, in dogs
Sadatoshi Kimoto +7 more
openalex +1 more source
Epilepsy as a dynamic disease: Toward actionable, individualized seizure risk prediction
Abstract The current definition of epilepsy allows diagnosis after a single unprovoked seizure if the estimated 10‐year recurrence risk is ≥60%. While this framework is grounded in epidemiological evidence, it does not align with the shorter time horizons that guide many clinical and personal decisions.
Kai Michael Schubert +3 more
wiley +1 more source
Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries. [PDF]
Htoo PT +5 more
europepmc +1 more source
Soy protein: The next antihypertensive agent? [PDF]
Ana M. Saldarriaga Cartagena
openalex +1 more source
ABSTRACT Aim This study aimed to investigate the independent associations of walking speed (WS) and hand grip strength (HGS) with the risk of hypertension in older adults. Methods We analyzed data from 1890 older adults participating in a Korean community‐based cohort study.
On Lee, DooYong Park
wiley +1 more source
Polypharmacy in HIV: Rethinking what counts and why it matters
Abstract Polypharmacy, the concurrent use of multiple medications, presents a growing challenge in HIV care as people living with HIV age and experience earlier onset of age‐related co‐morbidities. However, how polypharmacy is defined and assessed in HIV research remains inconsistent.
Luxsena Sukumaran +6 more
wiley +1 more source

